PT Indofarma Tbk reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was IDR 2,901,986.53 million compared to IDR 1,715,587.65 million a year ago. Net loss was IDR 37,580.64 million compared to net income of IDR 27.58 million a year ago. Basic loss per share from continuing operations was IDR 12.12 compared to basic earnings per share from continuing operations of IDR 0.01 a year ago. Diluted loss per share from continuing operations was IDR 12.12 compared to diluted earnings per share from continuing operations of IDR 0.01 a year ago.